Bookvolume editor, Daniel Martins-de-Souza.
Contents:
Proteomic characterization of the brain and cerebrospinal fluid of schizophrenia patients / Caf-Mendes, C.C.; Gattaz, W.F.; Schmitt, A.; Britto, L.R.G.; Martins-de-Souza, D
Peripheral biomarker candidates in schizophrenia / Thome, J.; Bratek, A.; Krysta, K
Schizophrenia : blood-serum-plasma metabolomics / Lista, S.; Giegling, I.; Rujescu, D
Proteomic and metabolomic evidence for glial alterations in schizophrenia / Beasley, C.L.; Barakauskas, V.E
Insights from proteomic studies on schizophrenia preclinical models : what can we learn for drug discovery? / Farrelly, L.A.; Fcking, M.; Cotter, D.R
Metabolomics to study psychotic disorders and their metabolic comorbidities / Oresi, M
Peripheral biomarkers for depression by plasma and serum proteomics / Domenici, E
Proteomics of preclinical models of depression / Carboni, L
Antidepressant response metabonomics / Qin, X.; Gao, X.; Qiao, Y.; Zhou, Y.; Tian, J.; Li, Z
Proteomics and metabolomics of bipolar disorder / Sussulini, A
Use of metabolomics and proteomics to reveal pathophysiological pathways in anxiety disorders / Altmaier, E.; Emeny, R.T.